Showing results (241-250 of 376) with videos related to
Sort By:
Pageof 38
American Journal of Preventive Cardiology|October 13, 2025
Coronary artery calcium burden across the pooled cohort equation versus the American Heart Association PREVENT risk calculatorGabrielle S Gershon, Jaret R Barr, Alexander C Razavi, et al.Journal of Clinical Microbiology|February 12, 1998
Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisonsD Brambilla, S Leung, J Lew, et al.Trends in Cardiovascular Medicine|June 23, 2020
Premature atherosclerotic peripheral artery disease: An underrecognized and undertreated disorder with a rising global prevalenceAnurag Mehta, Devinder S Dhindsa, Ananya Hooda, et al.European Journal of Preventive Cardiology|September 6, 2017
Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice projectSuzanne V Arnold, Silvio E Inzucchi, Fengming Tang, et al.AIDS (London, England)|November 24, 1999
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance ProgramD Brambilla, P S Reichelderfer, J W Bremer, et al.American Heart Journal|July 18, 2018
Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR)Suzanne V Arnold, Justin B Echouffo-Tcheugui, Carolyn S P Lam, et al.The New England Journal of Medicine|November 28, 1996
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study GroupR S Sperling, D E Shapiro, R W Coombs, et al.JAMA Cardiology|May 18, 2022
Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk PopulationsChang Liu, Devinder Dhindsa, Zakaria Almuwaqqat, et al.The New England Journal of Medicine|November 6, 2015
Soluble Urokinase Receptor and Chronic Kidney DiseaseSalim S Hayek, Sanja Sever, Yi-An Ko, et al.Circulation|November 18, 2000
Functional living trileaflet heart valves grown in vitroS P Hoerstrup, R Sodian, S Daebritz, et al.Pageof 38